Sartorius Corporation

Incucyte® SX5 Live-Cell Analysis System

Essen Bioscience, A Sartorius Company

Sinommune™: Coronavirus Antigen Array

Sino Biological Inc

NutriFreez® D10 Cryopreservation Medium

Biological Industries

Collaboration to Produce AT-100 as Promising New Candidate for Coronavirus

Airway Therapeutics, Inc. and Celonic Group have announced a collaboration to produce the novel human recombinant protein AT-100 (rhSP-D) as a therapeutic candidate against COVID-19.

300 Antibodies Generated That Have Neutralization Potential Against SARS-CoV-2

Prellis Biologics, Inc. announced that it has generated 300 human IgG antibodies that bind to either the S1 or S2 spike protein of the SARS-CoV2-Wuhan strain of the novel coronavirus.

Cell Line Development for Difficult-to-express Proteins

Horizon’s CHOSOURCE platform is to be combined with Rentschler Biopharma’s novel in-house cell line development process to provide speed, stability and high yield of difficult-to-express proteins.

Positive Interim Phase 1 Data for mRNA Vaccine Against SARS-CoV-2

Moderna, Inc. announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).